Vivatides Therapeutics: Valuation, Funding & Investors
Vivatides Therapeutics is a global biotechnology company developing extrahepatic RNA-targeting therapeutics. It focuses on advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies, building an extrahepatic delivery platform and progressing multiple pipeline programs toward clinical development.
Leadership & Board
- Current Number of Employees
- 5
- Current LinkedIn Followers
- 2,556
Latest Estimated Valuation
- Total Amount Raised
- $54M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $54M
- Latest Funding Round
- Series A
Employee Trend
Vivatides Therapeutics had 5 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Vivatides Therapeutics had 2,556 followers as of November 16, 2026. The number of followers increased by 19 (0.75%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 10, 2026 | Series A | $54.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Qiming Venture Partners | Series A |
| Highlight Capital | Series A |
| TF Capital | Series A |
| Apricot Capital | Series A |
Similar Companies
A snapshot of private companies similar to Vivatides Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis








